← Back to Screener
Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY)
Price$45.02
Value ScoreB
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-20.50%
Price vs S&P 500 (4W)2.97%
VGM Score61.00
Market Capitalization$106.60B
P/E Ratio (Annual)11.80x
Indicated Dividend Yield (Annual)5.39%
All Metrics
P/CF (Annual)8.44x
Book Value / Share (Quarterly)$69.66
P/TBV (Annual)2.23x
Indicated Dividend (Annual)$4.76
Revenue Growth (3Y)0.97%
Cash Flow / Share (Quarterly)$5.46
Payout Ratio (TTM)122.16%
Price vs S&P 500 (YTD)-15.83%
Gross Margin (TTM)72.45%
Net Profit Margin (TTM)17.19%
EPS (TTM)$11.57
10-Day Avg Trading Volume2.36M
EPS Excl Extra (TTM)$11.57
Revenue Growth (5Y)4.57%
EPS (Annual)$7.37
Dividend / Share (Annual)$4.48
ROI (Annual)8.52%
Gross Margin (Annual)72.07%
Net Profit Margin (5Y Avg)15.32%
Cash / Share (Quarterly)$5.30
P/E Basic Excl Extra (TTM)7.54x
Revenue Growth QoQ (YoY)16.46%
EPS Growth (5Y)-8.16%
P/E Normalized (Annual)11.80x
ROA (Last FY)6.16%
Revenue Growth TTM (YoY)43.69%
EBITD / Share (TTM)$14.11
ROE (5Y Avg)9.13%
Operating Margin (TTM)16.99%
Cash Flow / Share (Annual)$7.07
P/B Ratio1.27x
P/B Ratio (Quarterly)1.38x
Net Income / Employee (Annual)$118,078
EV / Revenue (TTM)1.50x
Net Interest Coverage (TTM)20.18x
ROA (TTM)9.60%
EPS Growth QoQ (YoY)-37.49%
EV / EBITDA (TTM)7.18x
EPS Incl Extra (Annual)$7.37
Current Ratio (Annual)1.09x
Quick Ratio (Quarterly)1.01x
3-Month Avg Trading Volume2.49M
52-Week Price Return-10.10%
EV / Free Cash Flow (Annual)14.45x
P/E Incl Extra (TTM)7.54x
Revenue / Employee (TTM)$1,075,423
Tangible BV / Share (Quarterly)$3.56
P/S Ratio (Annual)1.97x
Asset Turnover (Annual)0.37x
52-Week High$91.15
Operating Margin (5Y Avg)18.18%
EPS Excl Extra (Annual)$7.37
CapEx CAGR (5Y)11.18%
Tangible BV CAGR (5Y)0.16%
26-Week Price Return-9.11%
Quick Ratio (Annual)0.70x
13-Week Price Return-1.62%
Total Debt / Equity (Annual)0.28x
Current Ratio (Quarterly)1.01x
Enterprise Value$123.34B
Revenue / Share Growth (5Y)5.15%
Asset Turnover (TTM)0.56x
Book Value / Share Growth (5Y)3.22%
Revenue / Employee (Annual)$706,270
Inventory Turnover (Annual)1.33x
Pretax Margin (Annual)13.22%
Cash / Share (Annual)$8.11
3-Month Return Std Dev22.75%
Gross Margin (5Y Avg)70.09%
Net Income / Employee (TTM)$184,923
EBITDA CAGR (5Y)-12.35%
EBITDA Interim CAGR (5Y)-5.69%
ROE (Last FY)10.95%
Net Interest Coverage (Annual)21.36x
EPS Basic Excl Extra (Annual)$7.37
P/FCF (TTM)15.90x
Receivables Turnover (TTM)7.45x
EV / Free Cash Flow (TTM)18.70x
Total Debt / Equity (Quarterly)0.28x
EPS Incl Extra (TTM)$11.57
Receivables Turnover (Annual)5.81x
ROI (TTM)13.16%
Dividend Growth Rate (5Y)4.29%
P/S Ratio (TTM)1.30x
Pretax Margin (5Y Avg)17.25%
Revenue / Share (Annual)$44.08
Tangible BV / Share (Annual)$43.21
Forward P/E8.65x
Free OCF CAGR (5Y)6.70%
Price vs S&P 500 (52W)-37.15%
P/E Ratio (TTM)7.54x
EPS Growth TTM (YoY)96.20%
Year-to-Date Return-5.77%
5-Day Price Return5.11%
EPS Normalized (Annual)$7.37
ROA (5Y Avg)5.28%
Net Profit Margin (Annual)16.72%
Month-to-Date Return3.53%
Cash Flow / Share (TTM)$10.54
EBITD / Share (Annual)$7.76
EPS Growth (3Y)-1.45%
Operating Margin (Annual)13.58%
LT Debt / Equity (Annual)0.20x
P/CF (TTM)8.65x
ROI (5Y Avg)7.15%
P/E Excl Extra (TTM)7.54x
LT Debt / Equity (Quarterly)0.17x
EPS Basic Excl Extra (TTM)$11.57
P/TBV (Quarterly)26.94x
Payout Ratio (Annual)61.08%
P/B Ratio (Annual)1.41x
Dividend / Share (TTM)$8.97
Inventory Turnover (TTM)1.68x
Pretax Margin (TTM)16.43%
Book Value / Share (Annual)$68.36
Price vs S&P 500 (13W)-12.12%
Net Margin Growth (5Y)-12.66%
Dividend Yield (TTM)10.35%
Beta0.98x
P/FCF (Annual)12.49x
Revenue / Share (TTM)$68.31
ROE (TTM)17.02%
52-Week Low$71.73
vGradeB
gGradeC
mGradeC
vgmGradeB
Show chart for
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.80
3.80
3.80
3.76
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share) | B | C | C | $45.02 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Sanofi is a diversified pharmaceutical company focused on immunology, vaccines, and rare diseases. Its flagship product, Dupixent, accounts for approximately 30% of total revenue and is jointly commercialized with Regeneron. The company generates 45% of revenue from the United States, 20% from Europe, and 6% from China.